Inspire Medical Systems announced Q3 2026 revenue of $206.7 million, a 7.9% decline mainly due to U.S. coding and reimbursement challenges. Despite an operating loss of $28.7 million, adjusted diluted EPS was $0.14, supported by a 20 basis point gross margin increase. The AMA approved new CPT codes for the Inspire V system, effective January 2028, expected to improve coding clarity and patient access. The company narrowed its 2026 revenue guidance to $850-$860 million and plans to focus on growth initiatives for 2027.
Inspire Medical Systems' Q3 2026 financial results provide context for health sector trends. For readers following health stocks, here is Pluang's market snapshot as of Nov 03, 2026 04:11 WIB: out of 150 priced US health-sector stocks, 48 rose and 100 fell. Notable movers include REGN at USD 927.38 with a 1-day change of +13.27% and Pluang order activity of 80% Sell / 20% Buy, DNA at USD 9.81 down 12.60%, and TWST at USD 152.02 down 12.36%.
Global Indemnity Group will postpone its third quarter 2026 earnings call originally scheduled for November 4 to January, when new CEO Jessica Buss will present her vision and priorities for the company. The company will still release its Q3 results ...
Lorraine Ben, former CEO of Lockheed Martin Canada, has joined Syntax Defence to provide expert counsel amid Canada's commitment to invest over half a trillion dollars in defence over the next decade. This includes $180 billion in procurement opportu...
Dianthus Therapeutics, a clinical-stage biotech company, granted stock options to three new non-executive employees as inducements for joining the company. The options cover 26,000 shares at an exercise price of $82.25, vesting over four years. This ...
Zentalis Pharmaceuticals awarded 136,000 non-qualified stock options to four newly hired employees as an inducement to join the company, under Nasdaq Listing Rule 5635(c)(4). The options have an exercise price of $1.85, matching the stock's closing p...
The Federal Home Loan Bank of Atlanta announced the election of three new member directors and the re-election of one independent director to its board for 2026. Suzanne DeFerie was named Chair and Kathy McKinney Vice Chair for 2027, ensuring experie...
